Latest bidding news! 2 provinces carry out centralized procurement, with a procurement volume of 3.36 billion

1、 An analysis of the bidding in November Hunan Province will carry out the implementation plan for the special centralized procurement of Antibacterials in public medical institutions in 2019 [1] The procurement varieties are amoxicillin, ampicillin and other 52 varieties, with the procurement quantity of 5654669 (ten thousand tablets, ten thousand tablets, ten thousand pieces), among which the procurement quantity of amoxicillin oral regular release dosage form 1 (250 mg) is 91.6949 million tablets, and the bidding data will be submitted online from November 12 to November 30, 2019 Hebei province carried out the centralized procurement of drugs for urban and rural residents in the outpatient department of hypertension and diabetes [2] The procurement varieties were 15 varieties, including 9 varieties of hypertension and 6 varieties of diabetes The deadline for submission of application materials: 9:00-11:00 on Wednesday, December 11, 2019 The catalogue of procurement varieties and specifications and the agreed procurement volume are as follows: According to the relevant requirements of the centralized bidding document for class II vaccine of Hainan Province (No.: hngp2019-ym), the disease prevention and control center of Hainan Province has formulated the price limit standard for class II vaccine catalog products in 2019, with the publicity time from November 20 to 29, 2019, and the catalog is as follows: the dynamic summary data source of bidding in all provinces and cities in November: the bid winning information query database of pharmaceutical intelligence Partial content source [1] http://yycg.hnsggzy.com/homepage/showdetailpage.aspx? Infoid = 12658 [2] http://www.hebyyjzcgw.cn/manage/info.aspx? Infoid = 627 to learn more about bidding dynamics, please click the link "https://db.yaozh.com/yaopinzhongbiao" to enter the Chinese standard information query database of pharmaceutical intelligence ~ responsible editor Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.